Oncolytics Biotech (TSX:ONC) Other Current Receivables : C$0.09 Mil (As of Mar. 2025)

View and export this data going back to 2000. Start your Free Trial

What is Oncolytics Biotech Other Current Receivables?

Oncolytics Biotech's Other Current Receivables for the quarter that ended in Mar. 2025 was C$0.09 Mil.

Oncolytics Biotech's quarterly Other Current Receivables declined from Sep. 2024 (C$0.10 Mil) to Dec. 2024 (C$0.07 Mil) but then increased from Dec. 2024 (C$0.07 Mil) to Mar. 2025 (C$0.09 Mil).

Oncolytics Biotech's annual Other Current Receivables declined from Dec. 2022 (C$0.52 Mil) to Dec. 2023 (C$0.02 Mil) but then increased from Dec. 2023 (C$0.02 Mil) to Dec. 2024 (C$0.07 Mil).

Oncolytics Biotech Other Current Receivables Historical Data

The historical data trend for Oncolytics Biotech's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncolytics Biotech Other Current Receivables Chart

Oncolytics Biotech Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Current Receivables

Get a 7-Day Free Trial

0.09

0.87

0.52

0.02

0.07

Oncolytics Biotech Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Current Receivables	Get a 7-Day Free Trial															0.10	1.57	0.10	0.07	0.09

Oncolytics Biotech Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Oncolytics Biotech Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Oncolytics Biotech's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncolytics Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncolytics Biotech Inc (TSX:ONC) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

ONCY:USA

Address

322 11th Avenue S.W, Suite 804, Calgary, AB, CAN, T2R 0C5

Website

https://www.oncolyticsbiotech.com

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

Executives